What's in Jiangxi Kvvit Pharmaceutical Co., Ltd.'s pipeline?

Jiangxi Kvvit Pharmaceutical Co., Ltd. has 4 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 2 in Phase 2, 1 in Phase 1.

Which companies overlap with Jiangxi Kvvit Pharmaceutical Co., Ltd.'s portfolio?

Top competitors by shared drug class: Bristol-Myers Squibb, GlaxoSmithKline, IlDong Pharmaceutical Co Ltd, Merck Sharp & Dohme LLC, National Institute of Allergy and Infectious Diseases (NIAID).

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/jiangxi-kvvit-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Jiangxi Kvvit Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief

Jiangxi Kvvit Pharmaceutical Co., Ltd. pipeline: 0 marketed, 0 filed, 1 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 2 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Suraxavir Marboxil	Suraxavir Marboxil	phase 3	Nucleotide reverse transcriptase inhibitor	HIV reverse transcriptase	Infectious diseases

Therapeutic area mix

Infectious diseases · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bristol-Myers Squibb · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
IlDong Pharmaceutical Co Ltd · 1 shared drug class
Merck Sharp & Dohme LLC · 1 shared drug class
National Institute of Allergy and Infectious Diseases (NIAID) · 1 shared drug class
Sun Yat-sen University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Jiangxi Kvvit Pharmaceutical Co., Ltd.:

Cite this brief

Drug Landscape (2026). Jiangxi Kvvit Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/jiangxi-kvvit-pharmaceutical-co-ltd. Accessed 2026-05-16.